102 assets in Soft Tissue Sarcoma

Therapeutic assets addressing Soft Tissue Sarcoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Trastuzumab Emtansine Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Vinorelbine Ditartrate Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)

Showing 101 to 102 of 102 assets

PreviousPage 3 of 3Next